The Bare Economy · Aug 20, 2026
Beyond the jab: Moderna’s mRNA cancer vaccine hits late-stage gold.
0Sign in to vote or save
Moderna and Merck just released Phase 3 results showing their personalized mRNA cancer vaccine cuts melanoma recurrence and spread. Here is the unvarnished breakdown.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.